Cleerly

About

Cleerly is a digital healthcare company focused on revolutionizing cardiovascular care through advanced technology. Founded in 2017, it utilizes machine learning algorithms to analyze coronary computed tomography angiography (CCTA) images, providing detailed insights into coronary artery disease. Cleerly's platform non-invasively measures atherosclerosis, stenosis, and the likelihood of ischemia, offering a comprehensive assessment of heart health. This approach enables clinicians to develop personalized treatment plans by quantifying plaque and characterizing its type, which is crucial for assessing heart attack risk. Cleerly's technology is built on extensive clinical research, including data from over 40,000 patients across multiple clinical trials. The company leverages Amazon Web Services (AWS) for scalable and secure data processing, ensuring rapid turnaround times for diagnostic reports. Cleerly's mission is to transform cardiovascular care by shifting the focus from risk factors to direct disease detection and treatment. Its solutions aim to improve health outcomes by empowering both clinicians and patients with actionable insights and personalized care pathways.